ImmunityBio, Inc. — Director's Dealing 2017

Sep 13, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2017-09-08

Reporting Person: GORLIN STEVE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-08	Common Stock	S	14723	$6.1208	Disposed	375002	Direct
2017-09-11	Common Stock	S	53307	$6.0305	Disposed	321695	Direct
2017-09-12	Common Stock	S	35811	$6.027	Disposed	285884	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	521720	Indirect

Footnotes

F1: Represents the weighted average share price of an aggregate total of 14,723 shares sold in the price range of $6.1031 to $6.15 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: Represents the weighted average share price of an aggregate total of 53,307 shares sold in the price range of $6.00 to $6.08 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Represents the weighted average share price of an aggregate total of 35,811 shares sold in the price range of $6.00 to $6.10 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.